Xxera/openscience/retractions

Record #53398

A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo

Yuyin Xu, Li Chen, Guilan Wang, Jiaming Zhou, Yixin Zhang, Yinze Wei, Yuanyuan Zhu, Jing Qin

Journal

Publisher

Springer - Biomed Central (BMC)

Original paper date

Nov 6, 2013

Original DOI

10.1186/1471-2407-13-527

Country

Institution

Department of Pathological Anatomy, Nantong University, Nantong, China · Department of Nephrology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China · Department of Pathology, Affiliated Tumor Hospital, Nantong University, Nantong, China · Biomics (Nantong) Co., Ltd, Nantong, China

Open access

No

Article type

Research Article

Broad categories

(BLS) Biology - Cancer (BLS) Genetics (HSC) Medicine - Oncology (HSC) Medicine - Pharmacology

Notes from Retraction Watch

See also: https://pubpeer.com/publications/A7BFFDEAAFCACC97B66E9B0004D73A

Citation lifecycle

How this paper is being cited

Pre-retraction

26

Same day

0

Post-retraction

4

% post-retraction

26.7%

~2.7 citations/yr before retraction · ~1.3 citations/yr after

— citing papers

Who is still citing this work

Loading…